Research Article
Factors Influencing Blood Concentration of Voriconazole and Therapeutic Drug Monitoring in Patients with Child–Pugh Class C Cirrhosis
Figure 2
Distribution of voriconazole trough plasma concentrations (Cmin) in two maintenance dose regimens.
(a) |
(b) |